CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

Clinical trial NCT04162340 · UNKNOWN

Trial details

NCT number: NCT04162340
Sponsor: iCell Gene Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

T Cell Lymphoma in Relapse Refractory T-Cell Lymphoma

Start date: 2019-07-11
Primary completion: 2021-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.